Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Bourstyn

Showing results (21-30 of 31) with videos related to

Pageof 4
Sort By:
The International Journal of Biological Markers|April 14, 2000
Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastasesC Salbe, P de Cremoux, C Bonneton, et al.
Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.
Bulletin Du Cancer|January 1, 1989
[Cancer of the breast: intensive treatment with bone marrow autografts]C Gisselbrecht, E Lepage, J M Extra, et al.
Bulletin Du Cancer|November 1, 1993
[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]S Culine, J M Extra, M Espie, et al.
La Revue De Medecine Interne|May 5, 2000
[Retrospective multivariate analysis of radio-pathological correlations of nonpalpable breast lesions. Experience of the Hospital Saint-Louis]P H Cottu, I Cojean-Zelek, E Bourstyn, et al.
British Journal of Cancer|June 1, 1994
p53 mutations and overexpression in locally advanced breast cancersA Faille, P De Cremoux, J M Extra, et al.
European Journal of Haematology|May 1, 1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapyC Fermé, P Brice, E Bourstyn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reactionP de Cremoux, J M Extra, M G Denis, et al.
Bulletin Du Cancer|May 28, 2009
[Sentinel node biopsy in breast cancer]E Hindié, D Groheux, M Espie, et al.
Pageof 4

Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
The International Journal of Biological Markers|April 14, 2000
Illegitimate villin transcripts in normal bone marrow precludes detection of colon cancer micrometastasesC Salbe, P de Cremoux, C Bonneton, et al.
Breast Cancer Research and Treatment|March 11, 1998
Is p53 a protein that predicts the response to chemotherapy in node negative breast cancer?A Degeorges, A de Roquancourt, J M Extra, et al.
Bulletin Du Cancer|January 1, 1989
[Cancer of the breast: intensive treatment with bone marrow autografts]C Gisselbrecht, E Lepage, J M Extra, et al.
Bulletin Du Cancer|November 1, 1993
[Promising results of bimonthly chemotherapy with high dose cyclophosphamide and epirubicin in induction treatment of inflammatory cancer of the breast]S Culine, J M Extra, M Espie, et al.
La Revue De Medecine Interne|May 5, 2000
[Retrospective multivariate analysis of radio-pathological correlations of nonpalpable breast lesions. Experience of the Hospital Saint-Louis]P H Cottu, I Cojean-Zelek, E Bourstyn, et al.
British Journal of Cancer|June 1, 1994
p53 mutations and overexpression in locally advanced breast cancersA Faille, P De Cremoux, J M Extra, et al.
European Journal of Haematology|May 1, 1991
Surgical restaging of advanced Hodgkin's disease after first line chemotherapyC Fermé, P Brice, E Bourstyn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 19, 2000
Familial invasive breast cancers: worse outcome related to BRCA1 mutationsD Stoppa-Lyonnet, Y Ansquer, H Dreyfus, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Detection of MUC1-expressing mammary carcinoma cells in the peripheral blood of breast cancer patients by real-time polymerase chain reactionP de Cremoux, J M Extra, M G Denis, et al.
Bulletin Du Cancer|May 28, 2009
[Sentinel node biopsy in breast cancer]E Hindié, D Groheux, M Espie, et al.
Pageof 4